Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 53%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia Inc. reported strong financial performance in its latest quarter, with patient payment volumes increasing to $1.181 billion, marking a year-over-year growth of 9.2%. Revenue growth reached 15.9% year-over-year, fueled by a significant rise in payment processing fees, which soared 44.8%, and an increase in total revenue per AHSC of 7.9%. Additionally, the company's pro forma operating margins improved to 23.2%, reflecting enhanced operational efficiency, while free cash flow surged to $28.5 million, illustrating strong cash generation capabilities.

Bears say

Phreesia's recent financial performance exhibited weaker-than-expected growth, with the company ending 4Q26 with 4,658 provider clients, falling short of the anticipated 4,700, and displaying a decline in year-over-year organic revenue growth from 13% to 7%. Additionally, the revenue contribution from AccessOne continues to decline, highlighting a concerning trend as its top line shrank from $49.2 million in 2023 to projections of $34.6 million through 3Q25. This underperformance is reflected in the stock's steep decline of 67% over the trailing twelve months, contrasting sharply with a 17% increase in the broader Russell 3000 index, indicating significant investor concern regarding the company’s growth trajectory and financial outlook.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 53% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.